Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AlconXSWX:ALCE 53 3-Year Dividend Growth Rate is 12.20% as of Mar. 2026, which is 46% below its 10-year median of 22.55. GuruFocus rates XSWX:ALCE with a GF Score™ of 53/100 and a GF Value™ of CHF74.21 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 223 Medical Devices & Instruments companies, Alcon ranks better than 66.82% on this metric.
The historical rank and industry rank for Alcon's 3-Year Dividend Growth Rate or its related term are showing as below:
XSWX:ALCE'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 12.2 Med: 22.55 Max: 32.9
Current: 12.2
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Alcon was 32.90% per year. The lowest was 12.20% per year. And the median was 22.55% per year.
XSWX:ALCE's 3-Year Dividend Growth Rate is ranked better than 66.82% of 223
companies
in the Medical Devices & Instruments industry
Industry Median: 5.5
vs XSWX:ALCE: 12.20
During the past 12 months, Alcon's average Dividends Per Share Growth Rate was 16.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 12.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 10 years, the highest Dividend Payout Ratio of Alcon was 0.11. The lowest was 0.05. And the median was 0.09.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
During the past 10 years, the highest Dividend Yield of Alcon was 0.56%. The lowest was 0.12%. And the median was 0.30%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alcon 3-Year Dividend Growth Rate Related Terms>
XSWX:ALCE vs ISRG, BDX, MDLN: 3-Year Dividend Growth Rate Comparison
For the Medical Instruments & Supplies subindustry, Alcon's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcon 3-Year Dividend Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Alcon's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Alcon's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 12.20% mean?
Alcon (XSWX:ALCE) has a 3-Year Dividend Growth Rate of 12.20% as of Mar. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Alcon and its competitors. This is 46% below median its historical median of 22.55. Over the past decade, Alcon's 3-Year Dividend Growth Rate has ranged from 12.20 to 32.90. According to the industry distribution chart, Alcon ranks #74 out of 223 companies in the Medical Devices & Instruments industry, placing it in the top 33.2%.
Is Alcon's 3-Year Dividend Growth Rate too high?
Alcon's current 3-Year Dividend Growth Rate of 12.20% is 46% below median its 10-year median of 22.55. Over the past 10 years, this metric has ranged from a low of 12.20 to a high of 32.90. The Medical Devices & Instruments industry median 3-Year Dividend Growth Rate is 5.50. Alcon's value of 12.20% is 121.8% above this industry median. Based on the distribution chart, Alcon ranks #74 out of 223 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Alcon has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcon's 3-Year Dividend Growth Rate compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Alcon ranks #74 out of 223 companies for 3-Year Dividend Growth Rate. This puts Alcon in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 5.50. Alcon's value of 12.20% is 121.8% above this benchmark. Historically, Alcon's own 3-Year Dividend Growth Rate has ranged from 12.20 to 32.90 over the past decade. While the company's 10-year median is 22.55 vs. the industry median of 5.50, Alcon has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Dividend Growth Rate among Medical Devices & Instruments companies is 5.50, based on 223 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcon's current 3-Year Dividend Growth Rate of 12.20% is 121.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Alcon and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Dividend Growth Rate is 5.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcon's current 3-Year Dividend Growth Rate is 12.20%, which is 46% below median its own 10-year median of 22.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcon stock overvalued right now?
Based on GuruFocus' analysis, Alcon (XSWX:ALCE) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF74.21, compared to a current price of CHF57.12 — trading 23% below its estimated fair value. The current 3-Year Dividend Growth Rate is 12.20%, which is 46% below median its 10-year median of 22.55 and 121.8% above the Medical Devices & Instruments industry median of 5.50. Alcon's overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Alcon (XSWX:ALCE), the current 3-Year Dividend Growth Rate is 12.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcon (XSWX:ALCE) Overvalued in 2026?
Based on GuruFocus' analysis, Alcon stock appears to be undervalued.
The current stock price of CHF57.12 is trading 23% below its estimated GF Value™ of CHF74.21.
GuruFocus considers Alcon to be Modestly Undervalued.
Key valuation signals for XSWX:ALCE:
3-Year Dividend Growth Rate: 12.20% (46% below median its 10-year median of 22.55)
GF Value™: CHF74.21 vs. price of CHF57.12 (23% below fair value)
Industry Position: 121.8% above the Medical Devices & Instruments median (#74 of 223)
No single metric tells the full story. See the XSWX:ALCE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
53GF Score
Get the complete analysis for XSWX:ALCE
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ALCE has been successfully added to your 
